✦ LIBER ✦

Moclobemide versus fluoxetine for double depression: A randomized double-blind study

✍ Scribed by Antonio Duarte; Hans Mikkelsen; Alexandra Delini-Stula

Book ID: 114057786
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 360 KB
Volume: 30
Category: Article
ISSN: 0022-3956
DOI: 10.1016/s0022-3956(96)00030-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Moclobemide and fluoxetine in atypical d

Moclobemide and fluoxetine in atypical depression: a double-blind trial

✍ J. Lonnqvist; S. Sihvo; E. Syvälahti; O. Kiviruusu 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Moclobemide and placebo in mild major de

Moclobemide and placebo in mild major depression: a double-blind randomized trial

✍ E. Ose; P. Holm 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 137 KB

Moclobemide versus fluoxetine for a majo

Moclobemide versus fluoxetine for a major depressive episode

✍ C. Reynaert; P. Janne; M. Parent; J. Mirel; L. Hazzen 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 550 KB

Randomized, double-blind comparison of v

Randomized, double-blind comparison of venlafaxine and fluoxetine for moderately depressed outpatients

✍ P. Nannenga 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Fluvoxamine versus fluoxetine in major d

Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison

✍ Jean Dalery; Adriaan Honig 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract A double‐blind, multinational study was conducted to compare the efficacy and safety of fluvoxamine and fluoxetine in outpatients with major depressive episode; 184 patients were randomised to fluvoxamine (100 mg/day) or fluoxetine (20 mg/day) for 6 weeks. Both drugs were effective and

A double-blind study with paroxetine vs

A double-blind study with paroxetine vs fluoxetine in depressive patients

✍ A. Ontiveros; C. Garcia-Barriga 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 168 KB